Survival mechanism of CD271-positive HNSCC and itstherapeutic intervention
Project/Area Number |
15K20238
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Otorhinolaryngology
|
Research Institution | Miyagi Prefectural Hospital Organization Miyagi Cancer Center |
Principal Investigator |
IMAI TAKAYUKI 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん先進治療開発研究部, 特任研究員 (80408583)
|
Co-Investigator(Renkei-kenkyūsha) |
MATSUURA Kazuto 地方独立法人宮城県立病院機構宮城県立がんセンター(研究所), がん先進治療開発研究部, 特任研究員 (70271947)
|
Research Collaborator |
TANAKA Nobuyuki 地方独立法人宮城県立病院機構宮城県立がんセンター(研究所), がん先進治療開発研究部, 部長 (60280872)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | CD271 / 頭頸部癌 / 頭頚部外科学 / 癌幹細胞 |
Outline of Final Research Achievements |
To determine a potential role of CD271 in a squamous cell carcinoma, CD271 was knock-downed by shRNA. CD271 mRNA knockdown inhibited both cell proliferation and migration. p42/44Erk inhibition as well as RhoA inhibition ameliorated the malignant phenotypes of hypopharyngeal HPCM2 cells. An anti-CD271 Ab, however, did not show a significant in vitro effect on the cells. Taken together, CD271 is shown to be a potential target for squamous cell carcinoma therapy.
|
Report
(3 results)
Research Products
(4 results)
-
[Journal Article] CD271 regulates the proliferation and motility of hypopharyngeal cancer cells2016
Author(s)
Mochizuki M, Tamai K, Imai T, Sugawara S, Ogama N, Nakamura M, Matsuura K, Yamaguchi K, Satoh K, Sato I, Motohashi H, Sugamura K, Tanaka N
-
Journal Title
Sci Rep
Volume: 6
Issue: 1
Pages: 30707-30707
DOI
Related Report
Peer Reviewed / Open Access
-
-
-